EIGR Insider Trading - Eiger BioPharmaceuticals, Inc.

Saham Orang Dalam

17,960,790 shares

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

N/A

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

N/A

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Eiger BioPharmaceuticals, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam	Rata-rata Keuntungan (%)	Saham Dimiliki	Terbagi Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di EIGR / Eiger BioPharmaceuticals, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Maksimal	Harga di Maksimal	Maksimal Keuntungan ($)	Maksimum Pengembalian (%)
2023-11-02	KAYNE RICHARD A	23,398	0.2977	780	8.9310	6,966	15	12.9	3,084	44.28
2023-11-01	KAYNE RICHARD A	100,000	0.2797	3,333	8.3910	27,970
2023-10-31	KAWAS LEEN	11,987	0.2625	400	7.8750	3,147
2023-10-31	KAWAS LEEN	12,345	0.2615	412	7.8450	3,228
2023-10-31	KAYNE RICHARD A	11,987	0.2625	400	7.8750	3,147
2023-10-31	KAYNE RICHARD A	12,345	0.2615	412	7.8450	3,228
2023-10-31	KAYNE RICHARD A	130,509	0.2414	4,350	7.2420	31,505
2023-01-23	Dietz Thomas John	50,000	1.4316	1,667	42.9480	71,580
2022-12-22	Glenn Jeffrey S	100,000	1.2795	3,333	38.3850	127,950

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

EIGR / Eiger BioPharmaceuticals, Inc. Insider Trades

Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di EIGR / Eiger BioPharmaceuticals, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Menit	Harga di Menit	Kerugian Maksimal Dihindari ($)	Kerugian Maksimal Dihindari (%)
2023-03-17	Mayer Eldon C. III	2,520	1.0700	84	32.1000	2,696	364	5.1400	-2,264	-83.99
2023-03-17	Mayer Eldon C. III	1,875	1.0707	62	32.1210	2,008
2022-12-29	Murray Christine	5,000	1.2208	167	36.6240	6,104
2022-12-22	Dietz Thomas John	22,500	1.1690	750	35.0700	26,302
2022-03-14	Mayer Eldon C. III	1,657	5.5973	55	167.9190	9,275
2022-03-14	Ryali Sriram	2,266	5.5973	76	167.9190	12,683
2022-01-07	Mayer Eldon C. III	1,560	4.9501	52	148.5030	7,722
2021-03-15	Loh Evan	2,000	10.1400	67	304.2000	20,280
2021-01-08	Mayer Eldon C. III	1,690	11.6800	56	350.4000	19,739

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas Tanggal	Perdagangan Tanggal	Formulir	Orang Dalam	Ticker	Judul Keamanan	Kode	Langsung	Latihan Harga	Satuan Harga	Unit Diubah	Nilai Diubah (1 ribu)	Sisa Pilihan	Sisa Saham
2023-11-02	2023-11-02	4	KAYNE RICHARD A See footnote.	EIGR	Common Stock	P - Purchase	I		0.2977	23,398	7		5,375,225
2023-11-02	2023-11-01	4	KAYNE RICHARD A See footnote.	EIGR	Common Stock	P - Purchase	I		0.2797	100,000	28		5,351,827
2023-11-02	2023-10-31	4	KAYNE RICHARD A See footnote.	EIGR	Common Stock	P - Purchase	I		0.2414	130,509	32		5,251,827
2023-11-02	2023-10-31	4	KAYNE RICHARD A See footnote.	EIGR	Common Stock	P - Purchase	I		0.2615	12,345	3		5,121,318
2023-11-02	2023-10-31	4	KAYNE RICHARD A See footnote.	EIGR	Common Stock	P - Purchase	I		0.2625	11,987	3		5,108,973
2023-11-02	2023-10-31	4	KAWAS LEEN See footnote.	EIGR	Common Stock	P - Purchase	I		0.2615	12,345	3		4,391,432
2023-11-02	2023-10-31	4	KAWAS LEEN See footnote.	EIGR	Common Stock	P - Purchase	I		0.2625	11,987	3		4,379,087
2023-10-30		3	KAYNE RICHARD A See footnote.	EIGR	Common Stock		I						1,667,100
2023-10-30		3	KAYNE RICHARD A See footnote.	EIGR	Common Stock		I						2,700,000
2023-10-30		3	KAYNE RICHARD A See footnote.	EIGR	Common Stock		I						729,886
2023-10-30		3	KAWAS LEEN	EIGR	Common Stock		I						1,667,100
2023-10-30		3	KAWAS LEEN	EIGR	Common Stock		I						2,700,000
2023-09-05		3	Choong Ingrid By Family Trust	EIGR	Common Stock		I						2,400
2023-09-05		3	Choong Ingrid	EIGR	Common Stock		D						31,100
2023-03-21	2023-03-17	4	Mayer Eldon C. III	EIGR	Common Stock	S - Sale	D		1.0707	-1,875	-2		56,073
2023-03-21	2023-03-17	4	Mayer Eldon C. III	EIGR	Common Stock	S - Sale	D		1.0700	-2,520	-3		57,948
2023-01-25	2023-01-23	4	Dietz Thomas John By Trust	EIGR	Common Stock	P - Purchase	I		1.4316	50,000	72		50,000
2023-01-03	2022-12-29	4	Murray Christine	EIGR	Common Stock	S - Sale	D		1.2208	-5,000	-6		11,000
2022-12-27	2022-12-22	4	Dietz Thomas John	EIGR	Common Stock	S - Sale	D		1.1690	-22,500	-26		21,000
2022-12-27	2022-12-22	4	Glenn Jeffrey S	EIGR	Common Stock	P - Purchase	D		1.2795	100,000	128		182,355
2022-08-18	2022-08-16	4	Apelian David	EIGR	Common Stock	S - Sale	D		9.8061	-5,000	-49		11,000
2022-03-14	2022-03-14	4	Ryali Sriram	EIGR	Common Stock	S - Sale	D		5.5973	-2,266	-13		41,566
2022-03-14	2022-03-14	4	Mayer Eldon C. III	EIGR	Common Stock	S - Sale	D		5.5973	-1,657	-9		60,468
2022-03-11	2022-03-11	4	Loh Evan	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		12,000		12,000
2022-03-11	2022-03-11	4	Loh Evan	EIGR	Common Stock	A - Award	D			6,000			14,000
2022-03-11	2022-03-11	4	Atkisson Erik	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		38,000		38,000
2022-03-11	2022-03-11	4	Atkisson Erik	EIGR	Common Stock	A - Award	D			6,000			6,000
2022-03-11	2022-03-11	4	Mayer Eldon C. III	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		98,000		98,000
2022-03-11	2022-03-11	4	Mayer Eldon C. III	EIGR	Common Stock	A - Award	D			16,000			62,125
2022-03-11	2022-03-11	4	Apelian David	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		12,000		12,000
2022-03-11	2022-03-11	4	Apelian David	EIGR	Common Stock	A - Award	D			6,000			16,000
2022-03-11	2022-03-11	4	Sablich Kim	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		12,000		12,000
2022-03-11	2022-03-11	4	Sablich Kim	EIGR	Common Stock	A - Award	D			6,000			6,000
2022-03-11	2022-03-11	4	Ryali Sriram	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		143,000		143,000
2022-03-11	2022-03-11	4	Ryali Sriram	EIGR	Common Stock	A - Award	D			24,000			43,832
2022-03-11	2022-03-11	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		12,000		12,000
2022-03-11	2022-03-11	4	Glenn Jeffrey S	EIGR	Common Stock	A - Award	D			6,000			82,355
2022-03-11	2022-03-11	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		24,000		24,000
2022-03-11	2022-03-11	4	Dietz Thomas John	EIGR	Common Stock	A - Award	D			6,000			43,500
2022-03-11	2022-03-11	4	Sachdev Amit	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		12,000		12,000
2022-03-11	2022-03-11	4	Sachdev Amit	EIGR	Common Stock	A - Award	D			6,000			16,000
2022-03-11	2022-03-11	4	Murray Christine	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		12,000		12,000
2022-03-11	2022-03-11	4	Murray Christine	EIGR	Common Stock	A - Award	D			6,000			16,000
2022-03-11	2022-03-11	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	5.10		281,000		281,000
2022-03-11	2022-03-11	4	Cory David A	EIGR	Common Stock	A - Award	D			47,000			169,183
2022-01-11	2022-01-07	4	Mayer Eldon C. III	EIGR	Common Stock	S - Sale	D		4.9501	-1,560	-8		46,125
2021-10-01	2021-09-30	4	Atkisson Erik	EIGR	Stock Option (Right to Buy)	A - Award	D	6.68		180,000		180,000
2021-07-30	2021-07-29	4	Mayer Eldon C. III	EIGR	Stock Option (Right to Buy)	A - Award	D	8.15		17,500		17,500
2021-07-30	2021-07-29	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	8.15		48,750		48,750
2021-07-30	2021-07-29	4	Ryali Sriram	EIGR	Stock Option (Right to Buy)	A - Award	D	8.15		30,000		30,000
2021-05-11	2021-05-10	4	Ryali Sriram	EIGR	Stock Option (Right to Buy)	A - Award	D	8.49		87,000		87,000
2021-04-23	2021-04-23	4	Sablich Kim	EIGR	Stock Option (right to buy)	A - Award	D	8.43		25,000		25,000
2021-04-12	2021-04-09	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		8.5000	1,000	8		37,500
2021-04-12	2021-04-09	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		8.4800	1,500	13		36,500
2021-03-15	2021-03-12	4	Shaffer James P	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		71,250		71,250
2021-03-15	2021-03-12	4	Shaffer James P	EIGR	Common Stock	A - Award	D			11,875			29,296
2021-03-15	2021-03-12	4	Sachdev Amit	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		10,000		10,000
2021-03-15	2021-03-12	4	Sachdev Amit	EIGR	Common Stock	A - Award	D			5,000			10,000
2021-03-15	2021-03-12	4	Ryali Sriram	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		97,500		97,500
2021-03-15	2021-03-12	4	Ryali Sriram	EIGR	Common Stock	A - Award	D			16,250			18,152
2021-03-15	2021-03-12	4	Patton Stephana Eilene	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		71,250		71,250
2021-03-15	2021-03-12	4	Patton Stephana Eilene	EIGR	Common Stock	A - Award	D			11,875			17,948
2021-03-15	2021-03-12	4	Murray Christine	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		10,000		10,000
2021-03-15	2021-03-12	4	Murray Christine	EIGR	Common Stock	A - Award	D			5,000			10,000
2021-03-15	2021-03-12	4	Mayer Eldon C. III	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		71,250		71,250
2021-03-15	2021-03-12	4	Mayer Eldon C. III	EIGR	Common Stock	A - Award	D			11,875			47,685
2021-03-15	2021-03-15	4	Loh Evan	EIGR	Common Stock	S - Sale	D		10.1400	-2,000	-20		8,000
2021-03-15	2021-03-12	4	Loh Evan	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		10,000		10,000
2021-03-15	2021-03-12	4	Loh Evan	EIGR	Common Stock	A - Award	D			5,000			10,000
2021-03-15	2021-03-12	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		10,000		10,000
2021-03-15	2021-03-12	4	Glenn Jeffrey S	EIGR	Common Stock	A - Award	D			5,000			76,355
2021-03-15	2021-03-12	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		20,000		20,000
2021-03-15	2021-03-12	4	Dietz Thomas John	EIGR	Common Stock	A - Award	D			5,000			35,000
2021-03-15	2021-03-12	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		281,000		281,000
2021-03-15	2021-03-12	4	Cory David A	EIGR	Common Stock	A - Award	D			47,000			117,846
2021-03-15	2021-03-12	4	Apelian David	EIGR	Stock Option (Right to Buy)	A - Award	D	9.99		10,000		10,000
2021-03-15	2021-03-12	4	Apelian David	EIGR	Common Stock	A - Award	D			5,000			10,000
2021-01-11	2021-01-08	4	Mayer Eldon C. III	EIGR	Common Stock	S - Sale	D		11.6800	-1,690	-20		35,810
2020-08-12	2020-08-12	4	Glenn Jeffrey S By spouse	EIGR	Common Stock	P - Purchase	I		11.4367	4,500	51		5,000
2020-08-12	2020-08-12	4	Glenn Jeffrey S By spouse	EIGR	Common Stock	P - Purchase	I		11.2750	500	6		500
2020-08-12	2020-08-11	4	Glenn Jeffrey S	EIGR	Common Stock	P - Purchase	D		11.4927	5,000	57		71,355
2020-03-17	2020-03-16	4	Glenn Jeffrey S	EIGR	Common Stock	P - Purchase	D		5.0271	30,000	151		66,355
2020-03-17	2020-03-16	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		4.9500	1,000	5		30,000
2020-03-13	2020-03-12	4	Ryali Sriram	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		65,000		65,000
2020-03-13	2020-03-05	4	Ryali Sriram	EIGR	Common Stock	A - Award	D		7.3100	229	2		1,628
2020-03-13	2020-03-12	4	Sachdev Amit	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		10,000		10,000
2020-03-13	2020-03-12	4	Sachdev Amit	EIGR	Common Stock	A - Award	D			5,000			5,000
2020-03-13	2020-03-12	4	Shaffer James P	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		50,000		50,000
2020-03-13	2020-03-05	4	Shaffer James P	EIGR	Common Stock	A - Award	D		7.3100	1,500	11		15,921
2020-03-13	2020-03-12	4	Loh Evan	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		10,000		10,000
2020-03-13	2020-03-12	4	Loh Evan	EIGR	Common Stock	A - Award	D			5,000			5,000
2020-03-13	2020-03-12	4	Murray Christine	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		10,000		10,000
2020-03-13	2020-03-12	4	Murray Christine	EIGR	Common Stock	A - Award	D			5,000			5,000
2020-03-13	2020-03-12	4	Patton Stephana Eilene	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		65,000		65,000
2020-03-13	2020-03-05	4	Patton Stephana Eilene	EIGR	Common Stock	A - Award	D		7.3100	820	6		4,820
2020-03-13	2020-03-12	4	Apelian David	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		10,000		10,000
2020-03-13	2020-03-12	4	Apelian David	EIGR	Common Stock	A - Award	D			5,000			5,000
2020-03-13	2020-03-12	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		20,000		20,000
2020-03-13	2020-03-12	4	Dietz Thomas John	EIGR	Common Stock	A - Award	D			5,000			29,000
2020-03-13	2020-03-12	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		230,000		230,000
2020-03-13	2020-03-05	4	Cory David A	EIGR	Common Stock	A - Award	D		7.3100	1,500	11		69,346
2020-03-13	2020-03-12	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	5.60		10,000		10,000
2020-03-13	2020-03-12	4	Glenn Jeffrey S	EIGR	Common Stock	A - Award	D			5,000			36,355
2020-01-31	2020-01-31	4	Mayer Eldon C. III	EIGR	Stock Option ( Right to Buy)	A - Award	D	12.36		150,000		150,000
2020-01-31	2020-01-31	4	Mayer Eldon C. III	EIGR	Common Stock	A - Award	D			7,500			37,500
2020-01-30	2020-01-24	4	Mayer Eldon C. III	EIGR	Common Stock	P - Purchase	D		13.5205	5,000	68		30,000
2020-01-13	2020-01-10	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		13.9400	4,000	56		24,000
2019-09-06	2019-09-05	4	Shaffer James P	EIGR	Common Stock	A - Award	D		7.9475	1,500	12		14,421
2019-09-06	2019-09-05	4	Cory David A	EIGR	Common Stock	A - Award	D		7.9475	1,500	12		67,846
2019-09-06	2019-09-05	4	Ryali Sriram	EIGR	Common Stock	A - Award	D		9.3670	149	1		1,399
2019-05-30	2019-05-30	4	Sachdev Amit	EIGR	Stock Option ( Right to Buy)	A - Award	D	11.13		25,000		25,000
2019-04-26	2019-02-04	4	Cory David A	EIGR	Common Stock	P - Purchase	D		11.2600	343	4		66,346
2019-04-23	2019-04-23	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		11.0990	5,000	55		20,000
2019-04-22	2019-04-22	4	Patton Stephana Eilene	EIGR	Common Stock	P - Purchase	D		11.0300	1,000	11		4,000
2019-04-22	2019-04-22	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		11.0500	5,000	55		15,000
2019-04-22	2019-04-22	4	Ryali Sriram	EIGR	Common Stock	P - Purchase	D		11.0822	1,250	14		1,250
2019-03-26	2019-03-21	4	Apelian David	EIGR	Stock Option ( Right to Buy)	A - Award	D	14.31		110,500		110,500
2019-03-26	2019-03-21	4	Shaffer James P	EIGR	Stock Option ( Right to Buy)	A - Award	D	14.31		50,000		50,000
2019-03-26	2019-03-05	4	Shaffer James P	EIGR	Common Stock	A - Award	D		7.9475	1,500	12		12,921
2019-03-26	2018-09-05	4	Shaffer James P	EIGR	Common Stock	A - Award	D		7.9475	1,500	12		11,421
2019-03-26	2018-03-05	4	Shaffer James P	EIGR	Common Stock	A - Award	D		8.0325	1,500	12		9,921
2019-03-26	2017-09-05	4	Shaffer James P	EIGR	Common Stock	A - Award	D		9.9025	1,500	15		8,421
2019-03-26	2017-03-06	4	Shaffer James P	EIGR	Common Stock	A - Award	D		8.2025	1,301	11		6,921
2019-03-26	2019-03-21	4	Murray Christine	EIGR	Stock Option ( Right to Buy)	A - Award	D	13.41		10,000		10,000
2019-03-26	2019-03-21	4	Cory David A	EIGR	Stock Option ( Right to Buy)	A - Award	D	14.31		200,000		200,000
2019-03-26	2019-03-05	4	Cory David A	EIGR	Common Stock	A - Award	D		7.9475	1,500	12		66,003
2019-03-26	2018-09-05	4	Cory David A	EIGR	Common Stock	A - Award	D		7.9475	1,500	12		64,503
2019-03-26	2018-03-05	4	Cory David A	EIGR	Common Stock	A - Award	D		8.0325	1,500	12		63,003
2019-03-26	2017-09-05	4	Cory David A	EIGR	Common Stock	A - Award	D		9.9025	1,500	15		61,503
2019-03-26	2017-03-06	4	Cory David A	EIGR	Common Stock	A - Award	D		8.2025	1,325	11		60,003
2019-03-25	2019-03-21	4	Loh Evan	EIGR	Stock Option ( Right to Buy)	A - Award	D	14.31		10,000		10,000
2019-03-25	2019-03-21	4	Glenn Jeffrey S	EIGR	Stock Option ( Right to Buy)	A - Award	D	14.31		10,000		10,000
2019-03-25	2019-03-21	4	Dietz Thomas John	EIGR	Stock Option ( Right to Buy)	A - Award	D	13.41		20,000		20,000
2019-03-25	2019-03-21	4	Mayer Eldon C. III	EIGR	Stock Option ( Right to Buy)	A - Award	D	13.41		10,000		10,000
2019-03-25		3	Patton Stephana Eilene	EIGR	Common Stock		D						6,000
2019-03-25		3	Patton Stephana Eilene	EIGR	Common Stock		D						6,000
2019-03-25		3	Patton Stephana Eilene	EIGR	Common Stock		D						6,000
2019-03-25	2019-03-21	4	Patton Stephana Eilene	EIGR	Stock Option ( Right to Buy)	A - Award	D	14.31		90,000		90,000
2019-02-06	2019-02-04	4	Cory David A	EIGR	Common Stock	P - Purchase	D		14.1300	227	3		58,678
2019-01-09	2019-01-07	4	Murray Christine	EIGR	Stock Option ( Right to Buy)	A - Award	D	12.00		25,000		25,000
2019-01-04	2019-01-03	4	Ryali Sriram	EIGR	Stock Option ( Right to Buy)	A - Award	D	10.46		90,000		90,000
2018-12-20	2018-12-20	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		9.9800	5,000	50		10,000
2018-12-10	2018-12-06	4	Dietz Thomas John	EIGR	Common Stock	P - Purchase	D		11.2600	5,000	56		5,000
2018-11-30	2018-11-29	4	Mayer Eldon C. III	EIGR	Common Stock	P - Purchase	D		10.2100	4,000	41		25,000
2018-11-28	2018-11-27	4	Mayer Eldon C. III	EIGR	Common Stock	P - Purchase	D		9.9210	7,500	74		15,000
2018-11-28	2018-11-26	4	Mayer Eldon C. III	EIGR	Common Stock	P - Purchase	D		9.7524	7,500	73		7,500
2018-11-28	2001-11-28	4	Mayer Eldon C. III	EIGR	Common Stock	P - Purchase	D		10.0745	6,000	60		21,000
2018-10-25		3	RA Capital Healthcare Fund LP	EIGR	Common Stock		I						4,830,916
2018-10-25		3	RA Capital Healthcare Fund LP	EIGR	Common Stock		I						4,830,916
2018-10-25		3	RA Capital Healthcare Fund LP	EIGR	Common Stock		I						4,830,916
2018-10-25		3	RA Capital Healthcare Fund LP	EIGR	Common Stock		I						4,830,916
2018-10-25		3	RA Capital Healthcare Fund LP	EIGR	Common Stock		I						4,830,916
2018-10-22	2018-10-18	4	INTERWEST PARTNERS X LP	EIGR	Common Stock	S - Sale	D		12.0010	-26,465	-318		1,362,327
2018-10-22	2018-10-18	4	INTERWEST PARTNERS X LP	EIGR	Common Stock	S - Sale	D		12.0717	-210,800	-2,545		1,388,792
2018-04-04	2018-04-02	4	Quan Joanne	EIGR	Stock Option (Right to Buy)	M - Exercise	D	2.06		-4,000		22,256
2018-04-04	2018-04-02	4	Quan Joanne	EIGR	Common Stock	S - Sale	D		10.0000	-4,000	-40		0
2018-04-04	2018-04-02	4	Quan Joanne	EIGR	Common Stock	M - Exercise	D		2.0600	4,000	8		4,000
2018-03-16	2018-03-14	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		190,000		190,000
2018-03-16	2018-03-14	4	Apelian David	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		37,000		37,000
2018-03-16	2018-03-14	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		10,000		10,000
2018-03-16	2018-03-14	4	Mayer Eldon C. III	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		10,000		10,000
2018-03-16	2018-03-14	4	Loh Evan	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		10,000		10,000
2018-03-16	2018-03-14	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		10,000		10,000
2018-03-16	2018-03-14	4	WELCH JAMES H	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		60,000		60,000
2018-03-16	2018-03-14	4	Quan Joanne	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		60,000		60,000
2018-03-16	2018-03-14	4	Shaffer James P	EIGR	Stock Option (Right to Buy)	A - Award	D	9.50		60,000		60,000
2018-01-09	2018-01-05	4	Mayer Eldon C. III	EIGR	Stock Option (right to buy)	A - Award	D	13.70		25,000		25,000
2018-01-09	2018-01-05	4	Apelian David	EIGR	Stock Option (Right to Buy)	A - Award	D	13.70		150,000		150,000
2017-10-06	2017-09-28	4	Apelian David	EIGR	Stock Option (Right to Buy)	A - Award	D	10.75		25,000		25,000
2017-09-18	2017-09-15	4	Loh Evan	EIGR	Stock Option (Right to Buy)	A - Award	D	11.15		25,000		25,000
2017-09-05	2017-09-01	4	Glenn Jeffrey S	EIGR	Common Stock	P - Purchase	D		9.5300	15,000	143		31,355
2017-04-14	2017-04-12	4	Kjellson Nina S	EIGR	Stock Option (Right to Buy)	A - Award	D	8.50		10,000		10,000
2017-04-13	2017-04-12	4	Bramlage Charles	EIGR	Stock Option (Right to Buy)	A - Award	D	8.50		10,000		10,000
2017-04-13	2017-04-12	4	ENGLEMAN EDGAR	EIGR	Stock Option (Right to Buy)	A - Award	D	8.50		10,000		10,000
2017-04-13	2017-04-12	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	8.50		10,000		10,000
2017-04-13	2017-04-12	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	8.50		10,000		10,000
2017-03-14	2017-03-09	4	Martins Eduardo Bruno	EIGR	Stock Option (Right to Buy)	A - Award	D	11.75		30,000		30,000
2017-03-14	2017-03-09	4	Quan Joanne	EIGR	Stock Option (Right to Buy)	A - Award	D	11.75		30,000		30,000
2017-03-14	2017-03-09	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	11.75		133,000		133,000
2017-03-14	2017-03-09	4	Shaffer James P	EIGR	Stock Option (Right to Buy)	A - Award	D	11.75		40,000		40,000
2017-03-14	2017-03-09	4	WELCH JAMES H	EIGR	Stock Option (Right to Buy)	A - Award	D	11.75		40,000		40,000
2016-11-21	2016-11-18	4	Glenn Jeffrey S By son	EIGR	Common Stock	P - Purchase	I		12.9000	460	6		460
2016-11-21	2016-11-17	4	Glenn Jeffrey S	EIGR	Common Stock	P - Purchase	D		12.7300	15,000	191		16,355
2016-09-15	2016-03-28	4/A	Bramlage Charles	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-09-15	2016-03-23	4/A	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		285,991		285,991
2016-09-15	2016-03-28	4/A	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		23,000		23,000
2016-09-15	2016-03-28	4/A	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-09-15	2016-03-28	4/A	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		30,000		30,000
2016-09-15	2016-03-28	4/A	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-09-15	2016-03-23	4/A	Martins Eduardo Bruno	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		65,216		65,216
2016-09-15	2016-03-23	4/A	Quan Joanne	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		53,452		53,452
2016-09-15	2016-03-23	4/A	Shaffer James P	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		60,699		60,699
2016-09-15	2016-03-23	4/A	WELCH JAMES H	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		57,571		57,571
2016-09-15	2016-03-28	4/A	ENGLEMAN EDGAR	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-09-15	2016-03-28	4/A	Kjellson Nina S	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-08-22	2016-08-18	4	Vivo Ventures VI, LLC By Vivo Ventures VI Affiliates Fund, L.P.	EIGR	Common Stock	P - Purchase	I		16.0000	1,364	22		12,996
2016-08-22	2016-08-18	4	Vivo Ventures VI, LLC By Vivo Ventures Fund VI, L.P.	EIGR	Common Stock	P - Purchase	I		16.0000	186,136	2,978		1,774,096
2016-08-19	2016-08-18	4	Shaffer James P	EIGR	Common Stock	P - Purchase	D		15.7000	3,125	49		5,620
2016-08-19	2016-08-18	4	Cory David A	EIGR	Common Stock	P - Purchase	D		15.7000	1,562	25		58,451
2016-06-22	2016-06-22	4	WELCH JAMES H	EIGR	Common Stock	P - Purchase	D		19.7944	500	10		2,500
2016-06-22	2016-06-20	4	WELCH JAMES H	EIGR	Common Stock	P - Purchase	D		19.7962	2,000	40		2,000
2016-06-14	2016-06-13	4	Shaffer James P	EIGR	Common Stock	P - Purchase	D		22.2000	420	9		2,495
2016-06-14	2016-06-13	4	Shaffer James P	EIGR	Common Stock	P - Purchase	D		22.1700	100	2		2,075
2016-06-14	2016-06-13	4	Shaffer James P	EIGR	Common Stock	P - Purchase	D		22.1600	730	16		1,975
2016-05-23	2016-05-23	4	Shaffer James P	EIGR	Common Stock	P - Purchase	D		19.9900	745	15		1,245
2016-05-23	2016-05-19	4	Shaffer James P	EIGR	Common Stock	P - Purchase	D		19.5200	500	10		500
2016-04-04	2016-03-28	4	ENGLEMAN EDGAR	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-04-01	2016-03-28	4	Bramlage Charles	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-04-01	2016-03-28	4	Kjellson Nina S	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-04-01	2016-03-28	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		23,000		23,000
2016-04-01	2016-03-28	4	Dietz Thomas John	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-04-01	2016-03-28	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		30,000		30,000
2016-04-01	2016-03-28	4	Glenn Jeffrey S	EIGR	Stock Option (Right to Buy)	A - Award	D	15.75		25,000		25,000
2016-03-31		3	Kjellson Nina S By limited partnership	EIGR	Common Stock		I						3,199,186
2016-03-31		3	Kjellson Nina S By limited partnership	EIGR	Common Stock		I						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-31		3	NASR KHALED	EIGR	Common Stock		D						3,199,186
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 2	EIGR	Common Stock		I						1,611,224
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 1	EIGR	Common Stock		I						3,187,552
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 2	EIGR	Common Stock		I						1,611,224
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 1	EIGR	Common Stock		I						3,187,552
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 2	EIGR	Common Stock		I						1,611,224
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 2	EIGR	Common Stock		I						1,611,224
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 1	EIGR	Common Stock		I						3,187,552
2016-03-28		3	Vivo Ventures Fund VI, L.P. See footnote 1	EIGR	Common Stock		I						3,187,552
2016-03-28		3	Cory David A	EIGR	Common Stock		D						144,128
2016-03-28		3	Cory David A	EIGR	Common Stock		D						144,128
2016-03-28		3	Cory David A See footnote 1	EIGR	Common Stock		I						117,589
2016-03-28		3	Cory David A See footnote 1	EIGR	Common Stock		I						117,589
2016-03-28	2016-03-23	4	WELCH JAMES H	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		57,571		57,571
2016-03-28	2016-03-23	4	Shaffer James P	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		60,699		60,699
2016-03-28	2016-03-23	4	Cory David A	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		285,991		285,991
2016-03-28	2016-03-23	4	Quan Joanne	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		53,452		53,452
2016-03-28	2016-03-23	4	Martins Eduardo Bruno	EIGR	Stock Option (Right to Buy)	A - Award	D	15.89		65,216		65,216
2016-03-25		3	Glenn Jeffrey S	EIGR	Common Stock		I						303,483
2016-03-25		3	Glenn Jeffrey S	EIGR	Common Stock		I						303,483
2016-03-25		3	Glenn Jeffrey S	EIGR	Common Stock		D						153,774
2016-03-25		3	Glenn Jeffrey S	EIGR	Common Stock		D						153,774
2016-03-25		3	ENGLEMAN EDGAR See footnote 1	EIGR	Common Stock		I						3,187,552
2016-03-25		3	ENGLEMAN EDGAR See footnote 2	EIGR	Common Stock		I						1,611,224
2016-03-25		3	ENGLEMAN EDGAR See footnote 1	EIGR	Common Stock		I						3,187,552
2016-03-25		3	ENGLEMAN EDGAR See footnote 2	EIGR	Common Stock		I						1,611,224
2015-06-30		3	EcoR1 Capital, LLC See Note	CLDN	Common Stock		I						5,686,340
2015-06-30		3	EcoR1 Capital, LLC See Note	CLDN	Common Stock		I						5,686,340
2015-06-05	2015-06-04	4	Alton Gregg H	CLDN	Stock option (right to buy)	A - Award	D	2.16		10,000		40,000
2015-06-05	2015-06-04	4	NARACHI MICHAEL	CLDN	Stock option (right to buy)	A - Award	D	2.16		10,000		50,000
2015-06-05	2015-06-04	4	COOPER GRAHAM K	CLDN	Stock option (right to buy)	A - Award	D	2.16		10,000		40,000
2015-06-05	2015-06-04	4	Honig Peter	CLDN	Stock option (right to buy)	A - Award	D	2.16		10,000		22,800
2015-04-07	2015-04-06	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	8.00		-6,629		645,717
2015-04-07	2015-04-06	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-41,302		652,346
2015-04-07	2015-04-06	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		18.4400	-6,629	-122		3,125
2015-04-07	2015-04-06	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		18.1600	-41,302	-750		9,754
2015-04-07	2015-04-06	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		8.0000	6,629	53		51,056
2015-04-07	2015-04-06	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		1.1200	41,302	46		44,427
2015-04-03	2015-04-01	4	TAKEYA RYAN K	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-4,444		139,574
2015-04-03	2015-04-01	4	TAKEYA RYAN K	CLDN	Common Stock	S - Sale	D		19.1300	-4,444	-85		1,432
2015-04-03	2015-04-01	4	TAKEYA RYAN K	CLDN	Common Stock	M - Exercise	D		1.1200	4,444	5		5,876
2015-04-03	2015-04-02	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	8.00		-1,012		150,726
2015-04-03	2015-04-02	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-10,000		151,738
2015-04-03	2015-04-02	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		16.9500	-1,012	-17		2,895
2015-04-03	2015-04-02	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		17.3300	-10,000	-173		3,907
2015-04-03	2015-04-02	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		8.0000	1,012	8		13,907
2015-04-03	2015-04-02	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		1.1200	10,000	11		12,895
2015-03-17		3	Jackson Andrew C.	CLDN	Common Stock		D						3,174
2015-03-17		3	Jackson Andrew C.	CLDN	Common Stock		D						3,174
2015-03-09	2015-03-09	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	8.00		-6,629		693,648
2015-03-09	2015-03-09	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-41,302		700,277
2015-03-09	2015-03-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		24.7100	-6,629	-164		3,125
2015-03-09	2015-03-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		24.8100	-41,302	-1,025		9,754
2015-03-09	2015-03-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		8.0000	6,629	53		51,056
2015-03-09	2015-03-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		1.1200	41,302	46		44,427
2015-03-09	2015-03-06	4	Honig Peter	CLDN	Stock option (right to buy)	M - Exercise	D	9.58		-5,000		12,800
2015-03-09	2015-03-06	4	Honig Peter	CLDN	Common Stock	S - Sale	D		25.0000	-5,000	-125		0
2015-03-09	2015-03-06	4	Honig Peter	CLDN	Common Stock	M - Exercise	D		9.5800	5,000	48		5,000
2015-03-09	2015-03-05	4	Honig Peter	CLDN	Stock option (right to buy)	M - Exercise	D	11.30		-2,200		17,800
2015-03-09	2015-03-05	4	Honig Peter	CLDN	Stock option (right to buy)	M - Exercise	D	11.30		-2,500		20,000
2015-03-09	2015-03-05	4	Honig Peter	CLDN	Common Stock	S - Sale	D		22.2900	-2,200	-49		0
2015-03-09	2015-03-05	4	Honig Peter	CLDN	Common Stock	S - Sale	D		22.5000	-2,500	-56		2,200
2015-03-09	2015-03-05	4	Honig Peter	CLDN	Common Stock	M - Exercise	D		11.3000	2,200	25		4,700
2015-03-09	2015-03-05	4	Honig Peter	CLDN	Common Stock	M - Exercise	D		11.3000	2,500	28		2,500
2015-03-09	2015-03-06	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	8.00		-4,000		161,738
2015-03-09	2015-03-06	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-10,000		165,738
2015-03-09	2015-03-06	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		22.4800	-4,000	-90		2,895
2015-03-09	2015-03-06	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		23.2900	-10,000	-233		6,895
2015-03-09	2015-03-06	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		8.0000	4,000	32		16,895
2015-03-09	2015-03-06	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		1.1200	10,000	11		12,895
2015-03-03	2015-03-02	4	TAKEYA RYAN K	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-7,777		144,018
2015-03-03	2015-03-02	4	TAKEYA RYAN K	CLDN	Common Stock	S - Sale	D		18.4800	-7,777	-144		1,432
2015-03-03	2015-03-02	4	TAKEYA RYAN K	CLDN	Common Stock	M - Exercise	D		1.1200	7,777	9		9,209
2015-02-10	2015-02-06	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	8.00		-4,000		175,738
2015-02-10	2015-02-06	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-10,000		179,738
2015-02-10	2015-02-06	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		16.0800	-4,000	-64		2,895
2015-02-10	2015-02-06	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		16.0800	-10,000	-161		6,895
2015-02-10	2015-02-06	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		8.0000	4,000	32		16,895
2015-02-10	2015-02-06	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		1.1200	10,000	11		12,895
2015-02-10	2015-02-09	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	8.00		-6,629		741,579
2015-02-10	2015-02-09	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-41,302		748,208
2015-02-10	2015-02-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		15.9400	-6,629	-106		3,125
2015-02-10	2015-02-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		15.8500	-41,302	-655		9,754
2015-02-10	2015-02-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		8.0000	6,629	53		51,056
2015-02-10	2015-02-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		1.1200	41,302	46		44,427
2015-02-03	2015-02-02	4	TAKEYA RYAN K	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-7,777		151,795
2015-02-03	2015-02-02	4	TAKEYA RYAN K	CLDN	Common Stock	S - Sale	D		16.3500	-7,777	-127		1,432
2015-02-03	2015-02-02	4	TAKEYA RYAN K	CLDN	Common Stock	M - Exercise	D		1.1200	7,777	9		9,209
2015-01-12	2015-01-09	4	RUDY JEFFREY J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-10,000		181,738
2015-01-12	2015-01-09	4	RUDY JEFFREY J	CLDN	Common Stock	S - Sale	D		18.5100	-10,000	-185		1,024
2015-01-12	2015-01-09	4	RUDY JEFFREY J	CLDN	Common Stock	M - Exercise	D		1.1200	10,000	11		11,024
2015-01-08	2015-01-06	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-41,302		789,510
2015-01-08	2015-01-06	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		17.5100	-41,302	-723		3,125
2015-01-08	2015-01-06	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		1.1200	41,302	46		44,427
2015-01-08	2015-01-07	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-20,000		189,738
2015-01-08	2015-01-07	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		17.3000	-20,000	-346		2,895
2015-01-08	2015-01-07	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		1.1200	20,000	22		22,895
2015-01-05	2015-01-02	4	TAKEYA RYAN K	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-7,777		159,572
2015-01-05	2015-01-02	4	TAKEYA RYAN K	CLDN	Common Stock	S - Sale	D		19.8800	-7,777	-155		1,432
2015-01-05	2015-01-02	4	TAKEYA RYAN K	CLDN	Common Stock	M - Exercise	D		1.1200	7,777	9		9,209
2015-01-05	2015-01-01	4	TAKEYA RYAN K	CLDN	Stock option (right to buy)	A - Award	D	19.53		-72,000		167,349
2015-01-05	2015-01-01	4	REED ELIZABETH E	CLDN	Stock option (right to buy)	A - Award	D	19.53		72,000		142,500
2015-01-05	2015-01-01	4	WIKLUND FREDRIK	CLDN	Stock option (right to buy)	A - Award	D	19.53		80,000		193,243
2015-01-05	2015-01-01	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	A - Award	D	19.53		-80,000		209,738
2015-01-05	2015-01-01	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	A - Award	D	19.53		-275,000		830,812
2015-01-05	2015-01-01	4	Cleveland Paul B	CLDN	Stock option (right to buy)	A - Award	D	19.53		140,000		417,500
2015-01-05	2015-01-01	4	RUDY JEFFREY J	CLDN	Stock option (right to buy)	A - Award	D	19.53		-80,000		191,738
2014-12-10	2014-12-09	4	RUDY JEFFREY J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-10,000		111,738
2014-12-10	2014-12-09	4	RUDY JEFFREY J	CLDN	Common Stock	S - Sale	D		15.0000	-10,000	-150		414
2014-12-10	2014-12-09	4	RUDY JEFFREY J	CLDN	Common Stock	M - Exercise	D		1.1200	10,000	11		10,414
2014-12-10	2014-12-09	4	ZSEBO KRISZTINA M	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-41,302		555,812
2014-12-10	2014-12-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	S - Sale	D		15.0000	-41,302	-620		1,531
2014-12-10	2014-12-09	4	ZSEBO KRISZTINA M	CLDN	Common Stock	M - Exercise	D		1.1200	41,302	46		42,833
2014-12-08	2014-12-05	4	LABA REBECQUE J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-20,000		129,738
2014-12-08	2014-12-05	4	LABA REBECQUE J	CLDN	Common Stock	S - Sale	D		12.7700	-20,000	-255		691
2014-12-08	2014-12-05	4	LABA REBECQUE J	CLDN	Common Stock	M - Exercise	D		1.1200	20,000	22		20,691
2014-12-02	2014-12-01	4	TAKEYA RYAN K	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-7,777		95,349
2014-12-02	2014-12-01	4	TAKEYA RYAN K	CLDN	Common Stock	S - Sale	D		12.0100	-7,777	-93		577
2014-12-02	2014-12-01	4	TAKEYA RYAN K	CLDN	Common Stock	M - Exercise	D		1.1200	7,777	9		8,354
2014-11-18	2014-11-14	4	RUDY JEFFREY J	CLDN	Stock option (right to buy)	M - Exercise	D	1.12		-18,000		121,738
2014-11-18	2014-11-14	4	RUDY JEFFREY J	CLDN	Common Stock	S - Sale	D		11.6700	-18,000	-210		0
2014-11-18	2014-11-14	4	RUDY JEFFREY J	CLDN	Common Stock	M - Exercise	D		1.1200	18,000	20		18,000
2014-06-20		3	Cleveland Paul B	CLDN	No securities are beneficially owned		D						0
2014-06-20	2014-06-19	4	Cleveland Paul B	CLDN	Stock option (right to buy)	A - Award	D	14.40		277,500		277,500
2014-06-11	2014-06-09	4	REED ELIZABETH E	CLDN	Stock option (right to buy)	A - Award	D	9.12		65,000		65,000
2014-05-29	2014-05-28	4	WIKLUND FREDRIK	CLDN	Stock option (right to buy)	A - Award	D	9.26		10,000		10,000
2014-05-21	2014-05-20	4	Yang Patrick Y	CLDN	Stock option (right to buy)	A - Award	D	9.58		10,000		10,000
2014-05-21	2014-05-20	4	Alton Gregg H	CLDN	Stock option (right to buy)	A - Award	D	9.58		10,000		10,000
2014-05-21	2014-05-20	4	NARACHI MICHAEL	CLDN	Stock option (right to buy)	A - Award	D	9.58		10,000		10,000
2014-05-21	2014-05-20	4	COOPER GRAHAM K	CLDN	Stock option (right to buy)	A - Award	D	9.58		10,000		10,000
2014-05-21	2014-05-20	4	Honig Peter	CLDN	Stock option (right to buy)	A - Award	D	9.58		10,000		10,000
2014-05-21	2014-05-20	4	Funder Joshua	CLDN	Stock option (right to buy)	A - Award	D	9.58		10,000		10,000
2014-03-20	2014-03-19	4	LABA REBECQUE J	CLDN	Stock Option (Right to Buy)	A - Award	D	12.58		10,000		10,000
2014-03-04		3	Yang Patrick Y	CLDN	No securities are beneficially owned.		D						0
2014-03-04	2014-03-02	4	Yang Patrick Y	CLDN	Stock option (right to buy)	A - Award	D	11.30		2,500		2,500
2014-03-04	2014-03-02	4	Yang Patrick Y	CLDN	Stock option (right to buy)	A - Award	D	11.30		10,000		10,000
2014-03-04		3	Honig Peter	CLDN	No securities are beneficially owned.		D						0
2014-03-04	2014-03-02	4	Honig Peter	CLDN	Stock option (right to buy)	A - Award	D	11.30		2,500		2,500
2014-03-04	2014-03-02	4	Honig Peter	CLDN	Stock option (right to buy)	A - Award	D	11.30		10,000		10,000
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Common Warrants	C - Conversion	D	5.61		25,481		25,481
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Series A-1 Preferred Warrants	C - Conversion	D	0.45		-318,266		0
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Convertible Promissory Notes	C - Conversion	D	8.00	8.0000	-16,537	-132	0
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	D			-17,146,250		0
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Common Stock	P - Purchase	D		8.0000	162,386	1,299		1,551,721
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Common Stock	C - Conversion	D		8.0000	16,537	132		1,389,335
2014-02-06	2014-02-04	4	Novartis Bioventures Ltd	CLDN	Common Stock	C - Conversion	D			1,372,798			1,372,798
2014-02-06	2014-02-04	4	NARACHI MICHAEL	CLDN	Common Stock	P - Purchase	D		8.0000	62,500	500		62,500
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Warrant to Purchase Common Stock-Right to Buy	C - Conversion	I	5.61		17,517		17,517
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Warrant to Purchase Series A-1 Preferred Stock-Right to Buy	C - Conversion	I	0.45		-218,806		0
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Convertible Promissory Notes	C - Conversion	I	8.00	8.0000	-11,370	-91	0
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	I			-11,788,047		0
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Common Stock	P - Purchase	I		8.0000	111,608	893		1,066,775
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Common Stock	C - Conversion	I		8.0000	11,370	91		955,167
2014-02-06	2014-02-04	4	Foley Todd	CLDN	Common Stock	C - Conversion	I			943,797			943,797
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Common Warrants	C - Conversion	I	5.61		20,833		20,833
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Series A-1 Preferred Warrants	C - Conversion	I	0.45		-260,859		0
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Convertible Promissory Notes	C - Conversion	I	8.00	8.0000	-13,553	-108	0
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Junior Preferred Stock	C - Conversion	I			-5,741,267		0
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	I			-11,573,520		0
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Common Stock	P - Purchase	I		8.0000	133,083	1,065		1,950,184
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Common Stock	C - Conversion	I		8.0000	13,553	108		1,817,101
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partne	CLDN	Common Stock	C - Conversion	I			459,668			1,803,548
2014-02-06	2014-02-04	4	Enterprise Partners Management LLC By entities affiliated with Enterprise Partners	CLDN	Common Stock	C - Conversion	I			926,621			1,343,880
2014-02-06	2014-02-04	4	WIKLUND FREDRIK	CLDN	Common Stock	P - Purchase	D		8.0000	20,000	160		20,000
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Common Warrants	C - Conversion	I	5.61		28,666		28,666
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Series A-1 Preferred Warrants	C - Conversion	I	0.45		-358,049		0
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Convertible Promissory Notes	C - Conversion	I	8.00	8.0000	-18,605	-149	0
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	I			-19,289,531		0
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Common Stock	P - Purchase	I		8.0000	182,681	1,461		1,745,683
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Common Stock	C - Conversion	I		8.0000	18,605	149		1,563,002
2014-02-06	2014-02-04	4	Kordel Johan Lundbeckfond Invest A/S	CLDN	Common Stock	C - Conversion	I			1,544,397			1,544,397
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Common Warrants	C - Conversion	D	5.61		28,666		28,666
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Series A-1 Preferred Warrants	C - Conversion	D	0.45		-358,049		0
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Convertible Promissory Notes	C - Conversion	D	8.00	8.0000	-18,605	-149	0
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	D			-19,289,531		0
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Common Stock	P - Purchase	D		8.0000	182,681	1,461		1,745,683
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Common Stock	C - Conversion	D		8.0000	18,605	149		1,563,002
2014-02-06	2014-02-04	4	Lundbeckfond Invest A/S	CLDN	Common Stock	C - Conversion	D			1,544,397			1,544,397
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Common Warrants	C - Conversion	I	5.61		53,807		53,807
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Series A-1 Preferred Warrants	C - Conversion	I	0.45		-672,060		0
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Convertible Promissory Notes	C - Conversion	I	8.00	8.0000	-23,145	-185	0
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	I			-11,788,047		0
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Common Stock	P - Purchase	I		8.0000	227,261	1,818		1,194,204
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Common Stock	C - Conversion	I		8.0000	23,145	185		966,943
2014-02-06	2014-02-04	4	Funder Joshua GBS Bioventures IV	CLDN	Common Stock	C - Conversion	I			943,798			943,798
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Common Warrants	C - Conversion	D	5.61		42,659		42,659
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Series A-1 Preferred Warrants	C - Conversion	D	0.45		-532,818		0
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Convertible Promissory Notes	C - Conversion	D	8.00	8.0000	-23,145	-185	0
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Series A-1 Convertible Preferred Stock	C - Conversion	D			-19,289,531		0
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Common Stock	P - Purchase	D		8.0000	227,261	1,818		1,794,803
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Common Stock	C - Conversion	D		8.0000	23,145	185		1,567,542
2014-02-06	2014-02-04	4	PFIZER INC	CLDN	Common Stock	C - Conversion	D			1,544,397			1,544,397
2014-01-29		3	Enterprise Partners Liquidating Trust VI By entities affiliated with Enterprise Partners	CLDN	Common Stock		I						417,259

Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.

Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.

Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)

Konversi turunan

Penjualan atau pengalihan sekuritas kembali ke perusahaan.

Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.

Pemberian sekuritas oleh atau kepada orang dalam.

Swap ekuitas dan transaksi lindung nilai serupa

Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)

Transaksi yang dilaporkan secara sukarela pada Formulir 4.

Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)

EIGR / Eiger BioPharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5